SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002992
Filing Date
2022-02-02
Accepted
2022-02-02 16:22:07
Documents
13
Period of Report
2022-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm   iXBRL 8-K 39847
2 ex10-1.htm EX-10.1 18704
  Complete submission text file 0001493152-22-002992.txt   233310

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20220131.xsd EX-101.SCH 3051
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20220131_lab.xml EX-101.LAB 34476
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20220131_pre.xml EX-101.PRE 22607
7 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3189
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 22583939
SIC: 3841 Surgical & Medical Instruments & Apparatus